Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

newcleo plc - Ordinary Shares (NQ:NWCL)

4.220 -0.280 (-6.22%)
Delayed Quote Updated: 4:00 PM EST, Nov 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about newcleo plc - Ordinary Shares

News headline image
newcleo to Host Q3 2026 Business Update Call on November 18, 2026
Conference call and webcast to be held at 8:30 a.m. ET / 2:30 p.m. CET 
From newcleo plc
Via GlobeNewswire
News headline image
newcleo Completes Acquisition of Bonifait Pesage, Bringing Nuclear-Grade Scales In-House
Latest step in newcleo’s vertical integration strategy secures weighing equipment supply for its US and European MOX fuel manufacturing programs 
From newcleo plc
Via GlobeNewswire
News headline image
newcleo Inaugurates Advanced Nuclear Fuel Engineering and Testing Center in France, Furthering the Industrial Deployment of its MOX Fuel Program.
From newcleo plc
Via GlobeNewswire
News headline image
newcleo plc Reports First Half 2026 Financial and Operational Results
From newcleo plc
Via GlobeNewswire
News headline image
Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo’s Board of Directors in January 2027
Magwood’s experience negotiating nuclear policy with dozens of governments will give newcleo invaluable insight as it licenses its reactor technology in new markets 
From Newcleo SA
Via GlobeNewswire
News headline image
Rütschi celebrates 80 years of industrial expertise rooted in Alsace, serving the French and international nuclear industry
From Newcleo SA
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.